Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.
Laboratory experiments with cancer cells reveal two ways in which tumors evade chemotherapy drugs designed to starve and kill them, a new study in Nature Metabolism shows.
